Pediatric Neurology Briefs (Dec 2001)

Migraine Prophylaxis with Divalproex

  • J Gordon Millichap

DOI
https://doi.org/10.15844/pedneurbriefs-15-12-3
Journal volume & issue
Vol. 15, no. 12
pp. 91 – 91

Abstract

Read online

The effectiveness and safety of divalproex sodium administered daily in migraine prophylaxis were evaluated in 23 children, ages 7 to 17 years (mean, 12.4 yrs), at Ohio State University College of Medicine, Children’s Hospital, Columbus, OH.

Keywords